We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 25 start-ups with an aggregate funding of $2.1b. The average funding per company in this subset is $85.7m.
Last update to the database: Feb 18, 2025. See changelog.
Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases
6
Funding Rounds
$356.3m
Money raised
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
6
Funding Rounds
$399.8m
Money raised
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
1
Funding Rounds
$225.0m
Money raised
A company developing anti-aging treatments using components derived from human blood.
3
Funding Rounds
$41.0m
Money raised
Develops medicines for patients suffering from Alzheimer's disease and other neurological disorders.
8
Funding Rounds
$92.7m
Money raised
Nutritas is a biotechnology company using artificial intelligence to help discover bioactive peptides.
1
Funding Rounds
$65.0m
Money raised
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
4
Funding Rounds
$7.1m
Money raised
Elysium Health is a health product manufacturing company founded in 2014 by Leonard Pershing Guarente.
3
Funding Rounds
$65.0m
Money raised
A biopharmaceutical company developing therapeutics for treating age-related diseases.
3
Funding Rounds
$105.0m
Money raised
A biotech company using technology created at Johns Hopkins School of Medicine for the development of neuroprotective agents for neurologic disorders like Alzheimer’s disease and Parkinson’s disease.
1
Funding Rounds
$36.0m
Money raised
NewLimit is a biotechnology company focusing on developing epigenetic reprogramming therapies that aid with illnesses that are normally associated with aging.
1
Funding Rounds
$40.0m
Money raised
Spring Discovery is a computational drug discovery platform for age-related diseases founded by Ben Kamens.
2
Funding Rounds
$22.3m
Money raised
A biopharmaceutical company developing and discovering treatment for age-related human diseases.
3
Funding Rounds
$17.0m
Money raised
Nanna Therapeutics is a drug discovery company for age-related diseases.
2
Funding Rounds
$1.2m
Money raised
BioAge Labs focuses on developing AI and systems biology-based solutions for slowing the aging process and treating age-related illnesses.
3
Funding Rounds
$123.9m
Money raised
Rokit Healthcare Inc. is a 4D Bioprinting and Biotechnology company.
3
Funding Rounds
$30.0m
Money raised
Rejuvenate Bio is a startup company that manipulates genetic make-up to reverse aging in dogs and human.
3
Funding Rounds
$15.3m
Money raised
BioViva USA develops bioinformatics-based healthcare solutions for biotechnology companies, medical researchers and patients.
2
Funding Rounds
$10.3m
Money raised
GERO is a small Molecules founded in 2015 by Maxim Kholin.
2
Funding Rounds
$4.4m
Money raised
Shift Bioscience is an AI-driven cell simulation platform founded in 2017 by Daniel Ives.
1
Funding Rounds
$16.0m
Money raised
Samumed is a biotechnology company focused on the medical research and development for tissue-level regeneration.
1
Funding Rounds
$438.0m
Money raised
iBeat is a San Francisco-based company founded in 2016.
2
Funding Rounds
$8.5m
Money raised
Life science company focused on developing therapeutic nutrition products through research and clinical science.
1
Funding Rounds
$8.9m
Money raised
Edifice Health is revolutionizing the way we measure inflammation and immune health with a novel artificial intelligence-based technology to help you change the course of your aging process.
1
Funding Rounds
$12.0m
Money raised
Longevica is a science-driven company with a mission to find mechanisms of life extension.
1
Funding Rounds
$2.5m
Money raised